Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
Abstract The aim of this letter to the editor is to summarize the results from three clinical trial programs evaluating delayed-release cysteamine bitartrate (DR-CYS), which demonstrated the long-term clinical benefits in patients with nephropathic cystinosis when dosed every 12 h. The authors of “A...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMC
2023-06-01
|
| Collection: | Orphanet Journal of Rare Diseases |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1186/s13023-023-02724-3 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|